OCGN Q1 2018 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$6M

Net Income

-$15M

EPS (Diluted)

$-32.16

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$2M

Stock-Based Comp.

$403,000

Balance Sheet

Total Assets

$21M

Total Liabilities

$41M

Stockholders' Equity

-$20M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$6M	-$7M	+10.8%
Net Income	-$15M	-$7M	-109.5%